NOT-HL-16-452: Notice of Availability of Frequently Asked Questions for RFA-HL-17-018 "Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)"

Notice of Availability of Frequently Asked Questions for RFA-HL-17-018 "Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)"

Notice Number: NOT-HL-16-452

Key Dates
Release Date: September 30, 2016

Related Announcements
RFA-HL-17-018

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice to inform potential applicants that NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding applications for RFA-HL-17-018 "Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)".

The FAQs are available at this site:

https://www.nhlbi.nih.gov/research/funding/faq-rfa-hl-17-018-core-clinical-centers-blood-and-marrow-transplant-clinical-trials-network-ug1

While not required, all applicants are encouraged to view the FAQs prior to submitting their application.

Inquiries

Please direct all inquiries to:

Nancy L. DiFronzo, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: difronzon@nhlbi.nih.gov